KineMed, Inc. Demonstrates Ground-breaking Solutions to De-risk Drug Development Using Translational Biomarker Assays at the Biotech Showcase 2011

(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today that David Fineman, KineMed’s CEO will present at the 2011 Biotech Showcase on Tuesday January 11th at 4:00 p.m. at the Parc 55 Windham Hotel -- Union Square, San Francisco. Mr. Fineman’s presentation will address the problem of attrition of drug candidates from clinical trials and showcase KineMed’s next generation in vivo sensors that de-risk drug discovery and development by predicting clinical outcomes.
MORE ON THIS TOPIC